Omeros Corporation (NASDAQ:OMER) announced that the company was invited by the organizers of the 2014 Biennial Conference of the Schizophrenia International Research Society (SIRS) to make an oral presentation on OMS824, the company’s phosphodiesterase 10 (PDE10) inhibitor in development for the treatment of schizophrenia and Huntington’s disease. Omeros Corporation (NASDAQ:OMER) shares after opening at $11.38 moved to $12.12 on last trade day and at the end of the day closed at $ 12.07. Company price to sales ratio in past twelve months was calculated as 251.96 and price to cash ratio as 28.59. Omeros Corporation (NASDAQ:OMER) showed a negative weekly performance of -1.39%.
Isis Pharmaceuticals, Inc. (NASDAQ:ISIS), the leader in antisense therapeutics, announced that management will present a company overview at the 13th Annual Needham Healthcare Conference on Tuesday, April 8 , 2014 at 12:50 p.m. ET in New York, NY.ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) shares advanced 8.84% in last trading session and ended the day on $43.21. ISIS return on equity ratio is recorded as -18.10% and its return on assets is -8.10%. ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) yearly performance is 153.88%.
InvenSense, Inc. (NYSE:INVN) the leading provider of MotionTracking™ system on chip (SoC) and Sounddevices, and Sonion A/S, the global leader in micro acoustic and micro mechanical technologies and solutions for hearing instruments, in-ear earphones and specialty headsets, announced a strategic alliance in which the two parties will cooperate in the development of MEMS microphones and related technologies for use in a broad range of hearing applications. InvenSense Inc (NYSE:INVN) shares moved up 4.27% in last trading session and was closed at $23.67 while trading in range of $22.77 – $23.82 – InvenSense Inc (NYSE:INVN) year to date (YTD) performance is 13.91%.
Zacks downgraded shares of Clean Energy Fuels Corp. (NASDAQ:CLNE) from a neutral rating to an underperform rating in a report issued on Tuesday, Analyst Ratings.Net reports. Clean Energy Fuels Corp (NASDAQ:CLNE) weekly performance is 1.59%. On last trading day company shares ended up $8.94. Clean Energy Fuels Corp (NASDAQ:CLNE) distance from 50-day simple moving average (SMA50) is -10.78%. Analysts mean target price for the company is $11.06.